Definitive Contract 75N93022C00035
Award Date
9/1/22
Potential Completion Date
8/31/27
Potential Value
$30M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Northwestern University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60611, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Northwestern University. The award is a 5-year definitive contract with a potential value of $25,631,560.21 to support the "Structural Genomics Centers for Infectious Diseases" program. This contract does not have a set-aside designation. As the prime contractor, Northwestern University will provide research,...
This is a $6,223,512.88 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, for "Targeted Clinical Research to Address Select Viral Infections". The contract has no set-aside designation. The prime contractor is Northwestern University, a private research university, which will be supported by multiple academic subcontractors including Georgetown University, Vanderbilt University...
This is a $9,983,467.70 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Chicago to identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines. The contract has a period of performance through April 30, 2026 and was originally solicited through a Broad Agency Announcement issued by NIAID in 2018. The University of Chicago is collaborating with the IIT Research Institute and the University of...
This is a $61,272,508.00 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Chicago for research and development activities. The contract does not have a set-aside designation, indicating the University of Chicago was selected as a prime contractor for this effort based on its extensive expertise and capabilities in this domain. The contract supports the evaluation and development of animal and animal replacement models for...
The University of Chicago was awarded a base contract valued at $6,438,323 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide bioinformatics resource centers for infectious diseases. As part of the larger Bioinformatics Resource Centers for Infectious Diseases program, potentially worth up to $42.8 million, the University will receive support through September 2024. Major subcontractors include the University of Virginia, J. Craig Venter...
This firm-fixed-price purchase order, valued at $24,455.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Chicago for the "ARIC Anthrax Study". The contract, which does not have a set-aside designation, is for the University of Chicago to perform "other functions" related to the study. The University of Chicago is a renowned private research institution that frequently receives federal funding through contracts and...
The University of Chicago was awarded a $5,656,759.38 Firm Fixed Price contract by the National Institute of Allergy and Infectious Diseases (NIAID) to develop vaccines for influenza using an immuno-modulator adjuvant and multi-platform approach. This contract, which does not have a set-aside designation, is part of a larger $146.3 million Indefinite Delivery Vehicle (IDV) that the university holds with NIAID for pre-clinical models of infectious diseases. The IDV supports the evaluation and...
This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Northwestern University. The $3,544,085.97 contract is part of the Cancer Prevention Agent Development Program and provides core infrastructure support for early-phase clinical research. The contract is a delivery order under a larger IDV (Indefinite Delivery Vehicle) contract titled "Cancer Prevention Agent Development Program 2012-2017"....
This is a definitive federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID) to Seattle Children's Hospital, a leading non-profit pediatric research institution, to provide scientific support related to the structural biology of infectious diseases. The contract has a total ceiling value of $32,903,521.00 and runs through August 31, 2027. It does not have a set-aside designation. The contract includes multiple subcontractors who will support the scientific...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Emory University. The $3,458,502.19 cost-no-fee contract is for "TARGETING THERAPEUTICS DEVELOPMENT TO RELIEVE BOTTLENECKS: OPTIMIZONG LEAD THERAPEUTIC COMPOUNDS AGAINST INFECTIOUS PATHOGENS." It has a period of performance through October 31, 2018. The contract is not designated as a set-aside. The contract has several...